Quick Answer
LakeShore Biopharma Co., Ltd. reported Total Revenue of $85.67 million for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $85.67M | -85.1% |
| 2024 | $573.42M | -16.6% |
| 2023 | $687.20M | +36.6% |
| 2022 | $502.95M | +95.7% |
| 2021 | $257.02M | — |
- LakeShore Biopharma Co., Ltd. showed a decrease of -85.1% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2025 period, LakeShore Biopharma Co., Ltd.’s total revenue has declined by 66.7% (from $257.02 million to $85.67 million).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: